HA-EglN2-pcDNA3 Citations (5)
Originally described in: Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer.Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP, Farese RV, Freeman RS, Carter BD, Kaelin WG, Schlisio S Cancer Cell. 2005 Aug . 8(2):155-67. PubMed Journal
Articles Citing HA-EglN2-pcDNA3
| Articles |
|---|
| Oxygen-dependent Regulation of Erythropoietin Receptor Turnover and Signaling. Heir P, Srikumar T, Bikopoulos G, Bunda S, Poon BP, Lee JE, Raught B, Ohh M. J Biol Chem. 2016 Apr 1;291(14):7357-72. doi: 10.1074/jbc.M115.694562. Epub 2016 Feb 4. PubMed |
| XIAP upregulates expression of HIF target genes by targeting HIF1alpha for Lys63-linked polyubiquitination. Park CV, Ivanova IG, Kenneth NS. Nucleic Acids Res. 2017 Jun 28. doi: 10.1093/nar/gkx549. PubMed |
| Betulinic Acid Hydroxamate is Neuroprotective and Induces Protein Phosphatase 2A-Dependent HIF-1alpha Stabilization and Post-transcriptional Dephosphorylation of Prolyl Hydrolase 2. Prados ME, Correa-Saez A, Unciti-Broceta JD, Garrido-Rodriguez M, Jimenez-Jimenez C, Mazzone M, Minassi A, Appendino G, Calzado MA, Munoz E. Neurotherapeutics. 2021 Aug 2. pii: 10.1007/s13311-021-01089-4. doi: 10.1007/s13311-021-01089-4. PubMed |
| Decoupling NAD(+) metabolic dependency in chondrosarcoma by targeting the SIRT1-HIF-2alpha axis. Suh J, Kim H, Min J, Yeon HJ, Hemberg M, Scimeca L, Wu MR, Kang HG, Kim YJ, Kim JH. Cell Rep Med. 2024 Jan 16;5(1):101342. doi: 10.1016/j.xcrm.2023.101342. Epub 2023 Dec 20. PubMed |
| Pseudohypoxia-Stabilized HIF2alpha Transcriptionally Inhibits MNRR1, a Druggable Target in MELAS. Purandare N, Pasupathi V, Xi Y, Rajan V, Vegh C, Firestine S, Kozicz T, Fribley AM, Grossman LI, Aras S. Cells. 2025 Jul 15;14(14):1078. doi: 10.3390/cells14141078. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.